I. Craig Henderson
Directeur/Membre du Conseil chez San Francisco Opera Association
Profil
I.
Craig Henderson is currently a Director at San Francisco Opera Association.
He was previously the Chief Executive Officer at SEQUUS Pharmaceuticals, Inc. from 1995 to 1999, President & Chief Executive Officer at ACCESS Oncology, Inc. from 2001 to 2004, Director at Cytel, Inc., and President at Keryx Biopharmaceuticals, Inc. from 2004 to 2008.
Henderson holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Grinnell College.
Postes actifs de I. Craig Henderson
Sociétés | Poste | Début |
---|---|---|
San Francisco Opera Association
San Francisco Opera Association Movies/EntertainmentConsumer Services San Francisco Opera Association owns and operates opera theater. It offers an array of training programs and performance opportunities for young artists under the support of the San Francisco Opera Center and the Merola Opera Program. The company was founded by Gaetano Merola in 1923 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de I. Craig Henderson
Sociétés | Poste | Fin |
---|---|---|
KERYX BIOPHARMACEUTICALS | President | 15/04/2008 |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | President | 01/01/2004 |
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | President | 01/01/1999 |
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Cytel, Inc. engages in the provision of data-focused clinical research services and software solutions for the design and analysis of clinical trials. Its services include strategic consulting, statistical genetics, biostatistics, CDISC, clinical data management, and medical writing. The company was founded by Cyrus Mehta and Nitin Patel in 1987 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Formation de I. Craig Henderson
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Grinnell College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Health Technology |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Health Technology |
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Cytel, Inc. engages in the provision of data-focused clinical research services and software solutions for the design and analysis of clinical trials. Its services include strategic consulting, statistical genetics, biostatistics, CDISC, clinical data management, and medical writing. The company was founded by Cyrus Mehta and Nitin Patel in 1987 and is headquartered in Cambridge, MA. | Technology Services |
San Francisco Opera Association
San Francisco Opera Association Movies/EntertainmentConsumer Services San Francisco Opera Association owns and operates opera theater. It offers an array of training programs and performance opportunities for young artists under the support of the San Francisco Opera Center and the Merola Opera Program. The company was founded by Gaetano Merola in 1923 and is headquartered in San Francisco, CA. | Consumer Services |